Inborn Errors Of Metabolism Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Inborn Errors Of Metabolism stocks.

Inborn Errors Of Metabolism Stocks Recent News

Date Stock Title
May 15 BMRN BioMarin: Short-Term Headwinds But Long-Term Opportunities Remain
May 14 BMRN BioMarin Pharmaceutical to lay off 170 employees
May 14 BMRN Evercore says biotech ‘winter is finally thawing’
May 14 AGIO Agios Pharmaceuticals to Present Clinical and Translational Data in Rare Blood Disorders at European Hematology Association 2024 Hybrid Congress
May 14 NTLA Intellia Therapeutics, Inc. (NTLA) Just Overtook the 50-Day Moving Average
May 14 SYBX Synlogic GAAP EPS of -$2.60 misses by $1.80
May 14 SYBX Synlogic Reports First Quarter 2024 Financial Results
May 13 NTLA Intellia Therapeutics: 3 Near-Term Pivotal In Vivo Gene Therapies
May 12 NTLA Earnings Beat: Intellia Therapeutics, Inc. (NASDAQ:NTLA) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
May 10 FOLD Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q1 2024 Earnings Call Transcript
May 10 NTLA Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q1 2024 Earnings Call Transcript
May 10 NTLA Intellia Therapeutics Q1 2024 Earnings: Aligns with Analyst Projections Amidst Strategic Advances
May 10 FOLD Amicus Therapeutics Inc (FOLD) Q1 2024 Earnings: Surpasses Revenue Estimates and Projects ...
May 10 NTLA Intellia's (NTLA) Q1 Earnings & Revenues Beat Estimates
May 10 FOLD Amicus (FOLD) Q1 Earnings Top, Sales Lag, '24 Outlook Updated
May 10 NTLA Intellia Therapeutics First Quarter 2024 Earnings: Beats Expectations
May 10 NTLA Q1 2024 Intellia Therapeutics Inc Earnings Call
May 10 FOLD Amicus Therapeutics (FOLD) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
May 9 FOLD Amicus Therapeutics, Inc. (FOLD) Q1 2024 Earnings Call Transcript
May 9 BMRN (BMRN) - Analyzing Biomarin Pharmaceutical's Short Interest
Inborn Errors Of Metabolism

Inborn Errors of Metabolism (IEM) are genetic disorders that affect the body's ability to break down and use certain nutrients. These disorders can cause a wide range of symptoms, including mental retardation, physical disabilities, and even death. IEMs are caused by mutations in genes that are responsible for the production of enzymes that are necessary for the body to break down and use certain nutrients. Treatment for IEMs typically involves dietary changes, enzyme replacement therapy, and/or medication.

Browse All Tags